Klein & Nobel Medical Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
as on 04-01-2025
- Revenue -8.17%
(FY 2021)
- Profit 40.10%
(FY 2021)
- Ebitda -30.08%
(FY 2021)
- Net Worth -4.96%
(FY 2021)
- Total Assets 31.06%
(FY 2021)
About Klein & Nobel Medical Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M.
Manpreet Singh, Daljeet Singh, and Mohinder Singh serve as directors at the Company.
- CIN/LLPIN
U52311PB2012PTC035870
- Company No.
035870
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jan 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Klein & Nobel Medical Technologies Private Limited offer?
Klein & Nobel Medical Technologies Private Limited offers a wide range of products and services, including Hospital and Medical Furniture, Hospital Chair, Wheel Chairs, Crutches and Walker, Wheelchairs, Electric Wheelchair, Manual Wheelchairs, Aluminum Wheelchair, Children Wheelchair.
Who are the key members and board of directors at Klein & Nobel Medical Technologies?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Manpreet Singh | Director | 24-Jan-2012 | Current |
Daljeet Singh | Director | 24-Jan-2012 | Current |
Mohinder Singh | Director | 24-Jan-2012 | Current |
Financial Performance of Klein & Nobel Medical Technologies.
Klein & Nobel Medical Technologies Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 8.17% decrease. The company also saw a substantial improvement in profitability, with a 40.1% increase in profit. The company's net worth dipped by a decrease of 4.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Klein & Nobel Medical Technologies?
In 2021, Klein & Nobel Medical Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Union Bank Of India Creation Date: 08 Jan 2013 | ₹0.50 M | Open |
Union Bank Of India Creation Date: 16 Aug 2012 | ₹2.00 M | Open |
How Many Employees Work at Klein & Nobel Medical Technologies?
Unlock and access historical data on people associated with Klein & Nobel Medical Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Klein & Nobel Medical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Klein & Nobel Medical Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.